
LINK . SPRINGER . COM {
}
Title:
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival | Breast Cancer Research
Description:
Introduction Presence of disseminated tumor cells (DTCs) in bone marrow (BM) and circulating tumor cells (CTC) in peripheral blood (PB) predicts reduced survival in early breast cancer. The aim of this study was to determine the presence of and alterations in DTC- and CTC-status in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy (NACT) and to evaluate their prognostic impact. Methods Bone marrow and peripheral blood were collected before NACT (BM1: n = 231/PB1: n = 219), at surgery (BM2: n = 69/PB2: n = 71), and after 12 months from start of NACT (BM3: n = 162/PB3: n = 141). Patients were included from 1997 to 2003 and followed until 2009 (or ten years follow-up). DTC- and CTC-status were determined by morphological evaluation of immunocytochemically detected cytokeratin-positive cells. The prognostic significance of DTCs/CTCs was assessed by univariate and multivariate Cox-regression analyses. Results Before NACT, DTCs and CTCs were detected in 21.2% and 4.9% of the patients, respectively. At surgery, 15.9% and 1.4% had DTC- and CTC-presence, compared to 26.5% and 4.3% at 12 months from start of NACT. Of patients for whom DTC results both before NACT and at 12 months were available, concordant results were observed in 68%, and 14 out of 65 had positive DTC-status at both time points. Presence of ≥ 1 DTC 12 months from start of NACT, but not at other time points, predicted reduced disease-free survival (DFS; HR 2.3, p = 0.003), breast cancer-specific survival (BCSS; HR 3.0, p < 0.001) and overall survival (OS; HR 2.8, p < 0.001). Before NACT, presence of ≥ 3 DTCs was also associated with unfavorable outcome, and reduced BCSS was observed for CTC-positive patients (HR 2.2, p = 0.046). In multivariate analysis, DTC status (</≥ 1 DTC) at 12 months after start of NACT remained as a prognostic factor for both DFS (HR 2.2, p = 0.005), BCSS (HR 2.6, p = 0.002) and OS (HR 2.6, p = 0.002). The survival for patients with change in DTC-status was determined by the DTC-status at 12 months. Conclusion Presence of DTCs after NACT indicated high risk for relapse and death, irrespective of the DTC-status before treatment. The results supports the potential use of DTC analysis as a monitoring tool during follow up, for selection of patients to secondary treatment intervention within clinical trials.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Health & Fitness
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure how the site profits.
Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {🔍}
cancer, patients, breast, tumor, cells, dtcs, pubmed, article, survival, dtc, google, scholar, study, treatment, results, cas, bone, analysis, marrow, chemotherapy, time, presence, bcss, status, primary, detection, nact, clinical, table, ctcs, disseminated, neoadjuvant, blood, prognostic, dfs, circulating, analyses, surgery, response, number, figure, advanced, months, university, aspiration, clin, res, central, locally, peripheral,
Topics {✒️}
neoadjuvant anthracycline-taxane-based chemotherapy article download pdf breast cancer-specific survival ficoll-hypaque density centrifugation cytokeratin-19 mrna-positive cells open-labeled multicenter study real-time rt-pcr detection multivariate cox-regression analyses epithelial-mesenchymal transition markers full size image breast cancer-specific death kaplan-meier survival curves locally advanced disease predicts reduced survival advanced breast cancer cytokeratin-positive cells detected monoclonal anti-alkaline phosphatase long-term prognostic impact metastatic breast cancer early breast cancer minimal residual disease kaplan-meier plot shown blood-circulating tumour cells operable breast cancer disease-free survival full access disseminated tumor cell genome-based molecular characterization norwegian cancer society high-risk group high risk group primary breast cancer breast cancer res tumor cell-shedding single tumor cell inflammatory breast cancer breast cancer prognostication breast cancer progresses privacy choices/manage cookies natl cancer inst single-cell sequencing authors’ original file median relapse-free follow tumour cell detection breast cancer patients locally advanced breast cancer death article number r117 unfavorable tumor biology dtc-negative group
Questions {❓}
- Does primary neoadjuvant systemic therapy eradicate minimal residual disease?
Schema {🗺️}
WebPage:
mainEntity:
headline:Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
description:Presence of disseminated tumor cells (DTCs) in bone marrow (BM) and circulating tumor cells (CTC) in peripheral blood (PB) predicts reduced survival in early breast cancer. The aim of this study was to determine the presence of and alterations in DTC- and CTC-status in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy (NACT) and to evaluate their prognostic impact. Bone marrow and peripheral blood were collected before NACT (BM1: n = 231/PB1: n = 219), at surgery (BM2: n = 69/PB2: n = 71), and after 12 months from start of NACT (BM3: n = 162/PB3: n = 141). Patients were included from 1997 to 2003 and followed until 2009 (or ten years follow-up). DTC- and CTC-status were determined by morphological evaluation of immunocytochemically detected cytokeratin-positive cells. The prognostic significance of DTCs/CTCs was assessed by univariate and multivariate Cox-regression analyses. Before NACT, DTCs and CTCs were detected in 21.2% and 4.9% of the patients, respectively. At surgery, 15.9% and 1.4% had DTC- and CTC-presence, compared to 26.5% and 4.3% at 12 months from start of NACT. Of patients for whom DTC results both before NACT and at 12 months were available, concordant results were observed in 68%, and 14 out of 65 had positive DTC-status at both time points. Presence of ≥ 1 DTC 12 months from start of NACT, but not at other time points, predicted reduced disease-free survival (DFS; HR 2.3, p = 0.003), breast cancer-specific survival (BCSS; HR 3.0, p < 0.001) and overall survival (OS; HR 2.8, p < 0.001). Before NACT, presence of ≥ 3 DTCs was also associated with unfavorable outcome, and reduced BCSS was observed for CTC-positive patients (HR 2.2, p = 0.046). In multivariate analysis, DTC status (</≥ 1 DTC) at 12 months after start of NACT remained as a prognostic factor for both DFS (HR 2.2, p = 0.005), BCSS (HR 2.6, p = 0.002) and OS (HR 2.6, p = 0.002). The survival for patients with change in DTC-status was determined by the DTC-status at 12 months. Presence of DTCs after NACT indicated high risk for relapse and death, irrespective of the DTC-status before treatment. The results supports the potential use of DTC analysis as a monitoring tool during follow up, for selection of patients to secondary treatment intervention within clinical trials.
datePublished:2012-08-14T00:00:00Z
dateModified:2012-08-14T00:00:00Z
pageStart:1
pageEnd:13
license:http://creativecommons.org/licenses/by/2.0/
sameAs:https://doi.org/10.1186/bcr3242
keywords:
Overall Survival
Advanced Breast Cancer
Circulate Tumor Cell
Bone Marrow Aspiration
Disseminate Tumor Cell
Cancer Research
Oncology
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig4_HTML.jpg
isPartOf:
name:Breast Cancer Research
issn:
1465-542X
volumeNumber:14
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Randi R Mathiesen
affiliation:
name:Institute for Cancer Research, Oslo University Hospital, The Radium Hospital
address:
name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Elin Borgen
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Anne Renolen
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Erik Løkkevik
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Jahn M Nesland
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Gun Anker
affiliation:
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
type:Organization
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
type:Organization
type:Person
name:Bjørn Østenstad
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Steinar Lundgren
affiliation:
name:St. Olav University Hospital
address:
name:Department of Oncology, St. Olav University Hospital, Trondheim, Norway
type:PostalAddress
type:Organization
name:Norwegian University of Science and Technology
address:
name:Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
type:PostalAddress
type:Organization
type:Person
name:Terje Risberg
affiliation:
name:University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø
address:
name:Department of Oncology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
type:PostalAddress
type:Organization
type:Person
name:Ingvil Mjaaland
affiliation:
name:Stavanger University Hospital
address:
name:Division of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
type:PostalAddress
type:Organization
type:Person
name:Gunnar Kvalheim
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Per Eystein Lønning
affiliation:
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
type:Organization
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
type:Organization
type:Person
name:Bjørn Naume
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
description:Presence of disseminated tumor cells (DTCs) in bone marrow (BM) and circulating tumor cells (CTC) in peripheral blood (PB) predicts reduced survival in early breast cancer. The aim of this study was to determine the presence of and alterations in DTC- and CTC-status in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy (NACT) and to evaluate their prognostic impact. Bone marrow and peripheral blood were collected before NACT (BM1: n = 231/PB1: n = 219), at surgery (BM2: n = 69/PB2: n = 71), and after 12 months from start of NACT (BM3: n = 162/PB3: n = 141). Patients were included from 1997 to 2003 and followed until 2009 (or ten years follow-up). DTC- and CTC-status were determined by morphological evaluation of immunocytochemically detected cytokeratin-positive cells. The prognostic significance of DTCs/CTCs was assessed by univariate and multivariate Cox-regression analyses. Before NACT, DTCs and CTCs were detected in 21.2% and 4.9% of the patients, respectively. At surgery, 15.9% and 1.4% had DTC- and CTC-presence, compared to 26.5% and 4.3% at 12 months from start of NACT. Of patients for whom DTC results both before NACT and at 12 months were available, concordant results were observed in 68%, and 14 out of 65 had positive DTC-status at both time points. Presence of ≥ 1 DTC 12 months from start of NACT, but not at other time points, predicted reduced disease-free survival (DFS; HR 2.3, p = 0.003), breast cancer-specific survival (BCSS; HR 3.0, p < 0.001) and overall survival (OS; HR 2.8, p < 0.001). Before NACT, presence of ≥ 3 DTCs was also associated with unfavorable outcome, and reduced BCSS was observed for CTC-positive patients (HR 2.2, p = 0.046). In multivariate analysis, DTC status (</≥ 1 DTC) at 12 months after start of NACT remained as a prognostic factor for both DFS (HR 2.2, p = 0.005), BCSS (HR 2.6, p = 0.002) and OS (HR 2.6, p = 0.002). The survival for patients with change in DTC-status was determined by the DTC-status at 12 months. Presence of DTCs after NACT indicated high risk for relapse and death, irrespective of the DTC-status before treatment. The results supports the potential use of DTC analysis as a monitoring tool during follow up, for selection of patients to secondary treatment intervention within clinical trials.
datePublished:2012-08-14T00:00:00Z
dateModified:2012-08-14T00:00:00Z
pageStart:1
pageEnd:13
license:http://creativecommons.org/licenses/by/2.0/
sameAs:https://doi.org/10.1186/bcr3242
keywords:
Overall Survival
Advanced Breast Cancer
Circulate Tumor Cell
Bone Marrow Aspiration
Disseminate Tumor Cell
Cancer Research
Oncology
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_Fig4_HTML.jpg
isPartOf:
name:Breast Cancer Research
issn:
1465-542X
volumeNumber:14
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Randi R Mathiesen
affiliation:
name:Institute for Cancer Research, Oslo University Hospital, The Radium Hospital
address:
name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Elin Borgen
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Anne Renolen
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Erik Løkkevik
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Jahn M Nesland
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Gun Anker
affiliation:
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
type:Organization
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
type:Organization
type:Person
name:Bjørn Østenstad
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Steinar Lundgren
affiliation:
name:St. Olav University Hospital
address:
name:Department of Oncology, St. Olav University Hospital, Trondheim, Norway
type:PostalAddress
type:Organization
name:Norwegian University of Science and Technology
address:
name:Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
type:PostalAddress
type:Organization
type:Person
name:Terje Risberg
affiliation:
name:University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø
address:
name:Department of Oncology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
type:PostalAddress
type:Organization
type:Person
name:Ingvil Mjaaland
affiliation:
name:Stavanger University Hospital
address:
name:Division of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
type:PostalAddress
type:Organization
type:Person
name:Gunnar Kvalheim
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
type:Person
name:Per Eystein Lønning
affiliation:
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
type:Organization
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
type:Organization
type:Person
name:Bjørn Naume
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Breast Cancer Research
issn:
1465-542X
volumeNumber:14
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Institute for Cancer Research, Oslo University Hospital, The Radium Hospital
address:
name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
name:St. Olav University Hospital
address:
name:Department of Oncology, St. Olav University Hospital, Trondheim, Norway
type:PostalAddress
name:Norwegian University of Science and Technology
address:
name:Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
type:PostalAddress
name:University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø
address:
name:Department of Oncology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
type:PostalAddress
name:Stavanger University Hospital
address:
name:Division of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
type:PostalAddress
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Randi R Mathiesen
affiliation:
name:Institute for Cancer Research, Oslo University Hospital, The Radium Hospital
address:
name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Elin Borgen
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Anne Renolen
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Erik Løkkevik
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Jahn M Nesland
affiliation:
name:Oslo University Hospital, The Radium Hospital
address:
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
type:Organization
name:Gun Anker
affiliation:
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
type:Organization
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
type:Organization
name:Bjørn Østenstad
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Steinar Lundgren
affiliation:
name:St. Olav University Hospital
address:
name:Department of Oncology, St. Olav University Hospital, Trondheim, Norway
type:PostalAddress
type:Organization
name:Norwegian University of Science and Technology
address:
name:Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
type:PostalAddress
type:Organization
name:Terje Risberg
affiliation:
name:University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø
address:
name:Department of Oncology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
type:PostalAddress
type:Organization
name:Ingvil Mjaaland
affiliation:
name:Stavanger University Hospital
address:
name:Division of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
type:PostalAddress
type:Organization
name:Gunnar Kvalheim
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:Per Eystein Lønning
affiliation:
name:University of Bergen
address:
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
type:PostalAddress
type:Organization
name:Haukeland University Hospital
address:
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
type:PostalAddress
type:Organization
name:Bjørn Naume
affiliation:
name:Oslo University Hospital
address:
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
type:PostalAddress
type:Organization
name:University of Oslo
address:
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Radium Hospital, Oslo, Norway
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
name:Department of Pathology, Oslo University Hospital, The Radium Hospital, Oslo, Norway
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
name:Department of Oncology, St. Olav University Hospital, Trondheim, Norway
name:Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
name:Department of Oncology, University Hospital of Northern Norway and Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway
name:Division of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
name:Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway
name:Department of Oncology, Haukeland University Hospital, Bergen, Norway
name:Division of Surgery and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway
name:Institute of Clinical medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
External Links {🔗}(179)
- Check the income stats for https://www.springernature.com/gp/authors
- Revenue of https://link.springernature.com/home/
- How much does https://order.springer.com/public/cart pull in?
- What's the financial intake of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- Get to know what's the income of https://breast-cancer-research.biomedcentral.com/about
- What's the income generated by https://submission.nature.com/new-submission/13058/3 each month?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2549203
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Pathological%20prognostic%20factors%20in%20stage%20I%20%28T1N0M0%29%20and%20stage%20II%20%28T1N1M0%29%20breast%20carcinoma%3A%20a%20study%20of%20644%20patients%20with%20median%20follow-up%20of%2018%20years&journal=J%20Clin%20Oncol&volume=7&pages=1239-1251&publication_year=1989&author=Rosen%2CPP&author=Groshen%2CS&author=Saigo%2CPE&author=Kinne%2CDW&author=Hellman%2CS
- Monthly income for https://doi.org/10.1093%2Fannonc%2Fmdm013
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17317675
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20prognostication%20and%20prediction%20in%20the%20postgenomic%20era&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdm013&volume=18&pages=1293-1306&publication_year=2007&author=Lonning%2CPE&author=Knappskog%2CS&author=Staalesen%2CV&author=Chrisanthar%2CR&author=Lillehaug%2CJR?
- How much does https://doi.org/10.1056%2FNEJMoa050434 net monthly?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16120859 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20pooled%20analysis%20of%20bone%20marrow%20micrometastasis%20in%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa050434&volume=353&pages=793-802&publication_year=2005&author=Braun%2CS&author=Vogl%2CFD&author=Naume%2CB&author=Janni%2CW&author=Osborne%2CMP&author=Coombes%2CRC&author=Schlimok%2CG&author=Diel%2CIJ&author=Gerber%2CB&author=Gebauer%2CG&author=Pierga%2CJY&author=Marth%2CC&author=Oruzio%2CD&author=Wiedswang%2CG&author=Solomayer%2CEF&author=Kundt%2CG&author=Strobl%2CB&author=Fehm%2CT&author=Wong%2CGY&author=Bliss%2CJ&author=Vincent-Salomon%2CA&author=Pantel%2CK bring in?
- https://doi.org/10.1158%2F1078-0432.CCR-10-2515 income
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21415211's total income per month
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Persistence%20of%20disseminated%20tumor%20cells%20in%20the%20bone%20marrow%20of%20breast%20cancer%20patients%20predicts%20increased%20risk%20for%20relapse--a%20European%20pooled%20analysis&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-10-2515&volume=17&pages=2967-2976&publication_year=2011&author=Janni%2CW&author=Vogl%2CFD&author=Wiedswang%2CG&author=Synnestvedt%2CM&author=Fehm%2CT&author=Juckstock%2CJ&author=Borgen%2CE&author=Rack%2CB&author=Braun%2CS&author=Sommer%2CH&author=Solomayer%2CE&author=Pantel%2CK&author=Nesland%2CJ&author=Friese%2CK&author=Naume%2CB?
- What's the income of https://doi.org/10.1158%2F1078-0432.CCR-04-0245?
- http://scholar.google.com/scholar_lookup?&title=Isolated%20tumor%20cells%20in%20bone%20marrow%20three%20years%20after%20diagnosis%20in%20disease-free%20breast%20cancer%20patients%20predict%20unfavorable%20clinical%20outcome&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-0245&volume=15&pages=5342-8&publication_year=2004&author=Wiedswang%2CG's revenue stream
- What is the monthly revenue of https://doi.org/10.1038%2Fsj.bjc.6605183?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19623181?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736820
- How much profit does http://scholar.google.com/scholar_lookup?&title=Detection%20of%20cytokeratin-19%20mRNA-positive%20cells%20in%20the%20peripheral%20blood%20and%20bone%20marrow%20of%20patients%20with%20operable%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6605183&volume=101&pages=589-597&publication_year=2009&author=Daskalaki%2CA&author=Agelaki%2CS&author=Perraki%2CM&author=Apostolaki%2CS&author=Xenidis%2CN&author=Stathopoulos%2CE&author=Kontopodis%2CE&author=Hatzidaki%2CD&author=Mavroudis%2CD&author=Georgoulias%2CV generate?
- How much income does https://doi.org/10.1002%2Fijc.21709 have?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16381016?
- What's http://scholar.google.com/scholar_lookup?&title=Monitoring%20of%20disseminated%20tumor%20cells%20in%20bone%20marrow%20in%20high-risk%20breast%20cancer%20patients%20treated%20with%20high-dose%20chemotherapy&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.21709&volume=118&pages=2877-2881&publication_year=2006&author=Drageset%2CV&author=Nesland%2CJM&author=Erikstein%2CB&author=Skovlund%2CE&author=Sommer%2CH&author=Anker%2CG&author=Wist%2CE&author=Lundgren%2CS&author=Bergh%2CJ&author=Kvalheim%2CG's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21699723 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218956 bring in each month?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20as%20prognostic%20and%20predictive%20markers%20in%20metastatic%20breast%20cancer%20patients%20receiving%20first-line%20systemic%20treatment&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr2907&volume=13&publication_year=2011&author=Giuliano%2CM&author=Giordano%2CA&author=Jackson%2CS&author=Hess%2CKR&author=de%20Giorgi%2CU&author=Mego%2CM&author=Handy%2CBC&author=Ueno%2CNT&author=Alvarez%2CRH&author=de%20Laurentiis%2CM&author=de%20Placido%2CS&author=Valero%2CV&author=Hortobagyi%2CGN&author=Reuben%2CJM&author=Cristofanilli%2CM?
- Earnings of https://doi.org/10.1200%2FJCO.2005.08.140
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15735118 rake in every month?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%3A%20a%20novel%20prognostic%20factor%20for%20newly%20diagnosed%20metastatic%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.08.140&volume=23&pages=1420-1430&publication_year=2005&author=Cristofanilli%2CM&author=Hayes%2CDF&author=Budd%2CGT&author=Ellis%2CMJ&author=Stopeck%2CA&author=Reuben%2CJM&author=Doyle%2CGV&author=Matera%2CJ&author=Allard%2CWJ&author=Miller%2CMC&author=Fritsche%2CHA&author=Hortobagyi%2CGN&author=Terstappen%2CLW?
- How much profit does https://doi.org/10.1056%2FNEJMoa040766 generate?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15317891
- How much profit is http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%2C%20disease%20progression%2C%20and%20survival%20in%20metastatic%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040766&volume=351&pages=781-791&publication_year=2004&author=Cristofanilli%2CM&author=Budd%2CGT&author=Ellis%2CMJ&author=Stopeck%2CA&author=Matera%2CJ&author=Miller%2CMC&author=Reuben%2CJM&author=Doyle%2CGV&author=Allard%2CWJ&author=Terstappen%2CLW&author=Hayes%2CDF making per month?
- Check the income stats for https://doi.org/10.1158%2F1078-0432.CCR-05-2821
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16857794?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cells%20at%20each%20follow-up%20time%20point%20during%20therapy%20of%20metastatic%20breast%20cancer%20patients%20predict%20progression-free%20and%20overall%20survival&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2821&volume=12&pages=4218-4224&publication_year=2006&author=Hayes%2CDF&author=Cristofanilli%2CM&author=Budd%2CGT&author=Ellis%2CMJ&author=Stopeck%2CA&author=Miller%2CMC&author=Matera%2CJ&author=Allard%2CWJ&author=Doyle%2CGV&author=Terstappen%2CLW?
- Check the income stats for https://doi.org/10.1093%2Fannonc%2Fmdm507
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18187488?
- How much does http://scholar.google.com/scholar_lookup?&title=Prognosis%20of%20women%20with%20stage%20IV%20breast%20cancer%20depends%20on%20detection%20of%20circulating%20tumor%20cells%20rather%20than%20disseminated%20tumor%20cells&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdm507&volume=19&pages=496-500&publication_year=2008&author=Bidard%2CFC&author=Vincent-Salomon%2CA&author=Sigal-Zafrani%2CB&author=Dieras%2CV&author=Mathiot%2CC&author=Mignot%2CL&author=Thiery%2CJP&author=Sastre-Garau%2CX&author=Pierga%2CJY make?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-08-0030 pull in monthly?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18980996
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Circulating%20tumor%20cell%20detection%20predicts%20early%20metastatic%20relapse%20after%20neoadjuvant%20chemotherapy%20in%20large%20operable%20and%20locally%20advanced%20breast%20cancer%20in%20a%20phase%20II%20randomized%20trial&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-0030&volume=14&pages=7004-7010&publication_year=2008&author=Pierga%2CJY&author=Bidard%2CFC&author=Mathiot%2CC&author=Brain%2CE&author=Delaloge%2CS&author=Giachetti%2CS&author=de%20Cremoux%2CP&author=Salmon%2CR&author=Vincent-Salomon%2CA&author=Marty%2CM?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21672237
- What are the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218950?
- How much profit does http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20significance%20of%20tumour%20cell%20detection%20in%20the%20peripheral%20blood%20versus%20the%20bone%20marrow%20in%20733%20early-stage%20breast%20cancer%20patients&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr2898&volume=13&publication_year=2011&author=Molloy%2CTJ&author=Bosma%2CAJ&author=Baumbusch%2CLO&author=Synnestvedt%2CM&author=Borgen%2CE&author=Russnes%2CHG&author=Schlichting%2CE&author=Van%27t%20Veer%2CLJ&author=Naume%2CB make?
- What's the income of https://doi.org/10.1200%2FJCO.2008.18.0497?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19332733 earn?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Cytokeratin-19%20mRNA-positive%20circulating%20tumor%20cells%20after%20adjuvant%20chemotherapy%20in%20patients%20with%20early%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.18.0497&volume=27&pages=2177-2184&publication_year=2009&author=Xenidis%2CN&author=Ignatiadis%2CM&author=Apostolaki%2CS&author=Perraki%2CM&author=Kalbakis%2CK&author=Agelaki%2CS&author=Stathopoulos%2CEN&author=Chlouverakis%2CG&author=Lianidou%2CE&author=Kakolyris%2CS&author=Georgoulias%2CV&author=Mavroudis%2CD?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-07-4758 rake in every month?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18451221 earning monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20the%20molecular%20detection%20of%20circulating%20tumor%20cells%20using%20a%20multimarker%20reverse%20transcription-PCR%20assay%20for%20cytokeratin%2019%2C%20mammaglobin%20A%2C%20and%20HER2%20in%20early%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-4758&volume=14&pages=2593-2600&publication_year=2008&author=Ignatiadis%2CM&author=Kallergi%2CG&author=Ntoulia%2CM&author=Perraki%2CM&author=Apostolaki%2CS&author=Kafousi%2CM&author=Chlouverakis%2CG&author=Stathopoulos%2CE&author=Lianidou%2CE&author=Georgoulias%2CV&author=Mavroudis%2CD
- How much profit does https://doi.org/10.1200%2FJCO.2005.04.5948 make?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16769987
- How much does http://scholar.google.com/scholar_lookup?&title=Predictive%20and%20prognostic%20value%20of%20peripheral%20blood%20cytokeratin-19%20mRNA-positive%20cells%20detected%20by%20real-time%20polymerase%20chain%20reaction%20in%20node-negative%20breast%20cancer%20patients&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.04.5948&volume=24&pages=3756-3762&publication_year=2006&author=Xenidis%2CN&author=Perraki%2CM&author=Kafousi%2CM&author=Apostolaki%2CS&author=Bolonaki%2CI&author=Stathopoulou%2CA&author=Kalbakis%2CK&author=Androulakis%2CN&author=Kouroussis%2CC&author=Pallis%2CT&author=Christophylakis%2CC&author=Argyraki%2CK&author=Lianidou%2CES&author=Stathopoulos%2CS&author=Georgoulias%2CV&author=Mavroudis%2CD rake in every month?
- What's the income of https://doi.org/10.1200%2FJCO.2007.10.6823?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17785706 generate monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=Measurement%20of%20residual%20breast%20cancer%20burden%20to%20predict%20survival%20after%20neoadjuvant%20chemotherapy&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.10.6823&volume=25&pages=4414-4422&publication_year=2007&author=Symmans%2CWF&author=Peintinger%2CF&author=Hatzis%2CC&author=Rajan%2CR&author=Kuerer%2CH&author=Valero%2CV&author=Assad%2CL&author=Poniecka%2CA&author=Hennessy%2CB&author=Green%2CM&author=Buzdar%2CAU&author=Singletary%2CSE&author=Hortobagyi%2CGN&author=Pusztai%2CL generate?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Neoadjuvant%20Chemotherapy%20Adapted%20by%20Interim%20Response%20Improves%20Overall%20Survival%20of%20Primary%20Breast%20Cancer%20Patients%20-%20Results%20of%20the%20GeparTrio%20Trial&publication_year=2011&author=von%20Minckwitz%2CG
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20697801
- Find out how much http://scholar.google.com/scholar_lookup?&title=Effect%20of%20neoadjuvant%20anthracycline-taxane-based%20chemotherapy%20in%20different%20biological%20breast%20cancer%20phenotypes%3A%20overall%20results%20from%20the%20GeparTrio%20study&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-010-1103-9&volume=124&pages=133-140&publication_year=2010&author=Huober%2CJ&author=von%20Minckwitz%2CG&author=Denkert%2CC&author=Tesch%2CH&author=Weiss%2CE&author=Zahm%2CDM&author=Belau%2CA&author=Khandan%2CF&author=Hauschild%2CM&author=Thomssen%2CC&author=Hogel%2CB&author=Darb-Esfahani%2CS&author=Mehta%2CK&author=Loibl%2CS earns monthly
- How much revenue does https://doi.org/10.1371%2Fjournal.pone.0003062 generate?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18725978?
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518116 make?
- Profit of http://scholar.google.com/scholar_lookup?&title=CHEK2%20mutations%20affecting%20kinase%20activity%20together%20with%20mutations%20in%20TP53%20indicate%20a%20functional%20pathway%20associated%20with%20resistance%20to%20epirubicin%20in%20primary%20breast%20cancer&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0003062&volume=3&publication_year=2008&author=Chrisanthar%2CR&author=Knappskog%2CS&author=Lokkevik%2CE&author=Anker%2CG&author=Ostenstad%2CB&author=Lundgren%2CS&author=Berge%2CEO&author=Risberg%2CT&author=Mjaaland%2CI&author=Maehle%2CL&author=Engebretsen%2CLF&author=Lillehaug%2CJR&author=Lonning%2CPE
- What's the financial outcome of https://doi.org/10.1371%2Fjournal.pone.0019249?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21556366?
- See how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083424 makes per month
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Predictive%20and%20prognostic%20impact%20of%20TP53%20mutations%20and%20MDM2%20promoter%20genotype%20in%20primary%20breast%20cancer%20patients%20treated%20with%20epirubicin%20or%20paclitaxel&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0019249&volume=6&publication_year=2011&author=Chrisanthar%2CR&author=Knappskog%2CS&author=Lokkevik%2CE&author=Anker%2CG&author=Ostenstad%2CB&author=Lundgren%2CS&author=Risberg%2CT&author=Mjaaland%2CI&author=Skjonsberg%2CG&author=Aas%2CT&author=Schlichting%2CE&author=Fjosne%2CHE&author=Nysted%2CA&author=Lillehaug%2CJR&author=Lonning%2CPE?
- What is the monthly revenue of https://doi.org/10.1038%2Fbjc.1977.42?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=856236
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025288's financial summary
- Revenue of http://scholar.google.com/scholar_lookup?&title=Assessment%20of%20response%20to%20therapy%20in%20advanced%20breast%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fbjc.1977.42&volume=35&pages=292-298&publication_year=1977&author=Hayward%2CJL&author=Carbone%2CPP&author=Heusen%2CJC&author=Kumaoka%2CS&author=Segaloff%2CA&author=Rubens%2CRD
- See how much https://doi.org/10.1093%2Fjnci%2F92.3.205 makes per month
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10655437?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=New%20guidelines%20to%20evaluate%20the%20response%20to%20treatment%20in%20solid%20tumors.%20European%20Organization%20for%20Research%20and%20Treatment%20of%20Cancer%2C%20National%20Cancer%20Institute%20of%20the%20United%20States%2C%20National%20Cancer%20Institute%20of%20Canada&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F92.3.205&volume=92&pages=205-216&publication_year=2000&author=Therasse%2CP&author=Arbuck%2CSG&author=Eisenhauer%2CEA&author=Wanders%2CJ&author=Kaplan%2CRS&author=Rubinstein%2CL&author=Verweij%2CJ&author=van%20Glabbeke%2CM&author=van%20Oosterom%2CAT&author=Christian%2CMC&author=Gwyther%2CSG?
- How profitable is http://www.nbcg.no/nbcg.blaaboka.html?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11751511 have monthly?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Detection%20of%20isolated%20tumor%20cells%20in%20bone%20marrow%20in%20early-stage%20breast%20carcinoma%20patients%3A%20comparison%20with%20preoperative%20clinical%20parameters%20and%20primary%20tumor%20characteristics&journal=Clin%20Cancer%20Res&volume=7&pages=4122-4129&publication_year=2001&author=Naume%2CB&author=Borgen%2CE&author=Kvalheim%2CG&author=Karesen%2CR&author=Qvist%2CH&author=Sauer%2CT&author=Kumar%2CT&author=Nesland%2CJM making per month?
- How much does https://doi.org/10.1177%2F32.2.6198355 make?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6198355?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Immunoenzymatic%20labeling%20of%20monoclonal%20antibodies%20using%20immune%20complexes%20of%20alkaline%20phosphatase%20and%20monoclonal%20anti-alkaline%20phosphatase%20%28APAAP%20complexes%29&journal=J%20Histochem%20Cytochem&doi=10.1177%2F32.2.6198355&volume=32&pages=219-229&publication_year=1984&author=Cordell%2CJL&author=Falini%2CB&author=Erber%2CWN&author=Ghosh%2CAK&author=Abdulaziz%2CZ&author=MacDonald%2CS&author=Pulford%2CKA&author=Stein%2CH&author=Mason%2CDY
- What's the total monthly financial gain of https://doi.org/10.1080%2F0032472031000141283?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20426539 make?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Standardization%20of%20the%20immunocytochemical%20detection%20of%20cancer%20cells%20in%20BM%20and%20blood%3A%20I.%20establishment%20of%20objective%20criteria%20for%20the%20evaluation%20of%20immunostained%20cells&journal=Cytotherapy&doi=10.1080%2F0032472031000141283&volume=1&pages=377-388&publication_year=1999&author=Borgen%2CE&author=Naume%2CB&author=Nesland%2CJM&author=Kvalheim%2CG&author=Beiske%2CK&author=Fodstad%2CO&author=Diel%2CI&author=Solomayer%2CEF&author=Theocharous%2CP&author=Coombes%2CRC&author=Smith%2CBM&author=Wunder%2CE&author=Marolleau%2CJP&author=Garcia%2CJ&author=Pantel%2CK generate?
- https://doi.org/10.1056%2FNEJMoa052122 income
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16236738 generate monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Trastuzumab%20plus%20adjuvant%20chemotherapy%20for%20operable%20HER2-positive%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa052122&volume=353&pages=1673-1684&publication_year=2005&author=Romond%2CEH&author=Perez%2CEA&author=Bryant%2CJ&author=Suman%2CVJ&author=Geyer%2CCE&author=Davidson%2CNE&author=Tan-Chiu%2CE&author=Martino%2CS&author=Paik%2CS&author=Kaufman%2CPA&author=Swain%2CSM&author=Pisansky%2CTM&author=Fehrenbacher%2CL&author=Kutteh%2CLA&author=Vogel%2CVG&author=Visscher%2CDW&author=Yothers%2CG&author=Jenkins%2CRB&author=Brown%2CAM&author=Dakhil%2CSR&author=Mamounas%2CEP&author=Lingle%2CWL&author=Klein%2CPM&author=Ingle%2CJN&author=Wolmark%2CN
- Discover the revenue of https://doi.org/10.1016%2FS0140-6736%2805%2966544-0
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Effects%20of%20chemotherapy%20and%20hormonal%20therapy%20for%20early%20breast%20cancer%20on%20recurrence%20and%2015-year%20survival%3A%20an%20overview%20of%20the%20randomised%20trials&journal=Lancet&doi=10.1016%2FS0140-6736%2805%2966544-0&volume=365&pages=1687-1717&publication_year=2005
- What's the profit of https://doi.org/10.1002%2Fcncr.26202?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21717428
- How much profit does http://scholar.google.com/scholar_lookup?&title=Disseminated%20tumor%20cells%20predict%20survival%20after%20neoadjuvant%20therapy%20in%20primary%20breast%20cancer&journal=Cancer&doi=10.1002%2Fcncr.26202&volume=118&pages=342-348&publication_year=2011&author=Hall%2CC&author=Krishnamurthy%2CS&author=Lodhi%2CA&author=Bhattacharyya%2CA&author=Anderson%2CA&author=Kuerer%2CH&author=Bedrosian%2CI&author=Singh%2CB&author=Lucci%2CA generate?
- How much does https://doi.org/10.1038%2Fsj.bjc.6604773 gross monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19034279
- http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20bone%20marrow%2C%20disseminated%20tumour%20cells%20and%20blood-circulating%20tumour%20cells%20in%20breast%20cancer%20patients%20after%20primary%20treatment&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6604773&volume=100&pages=160-166&publication_year=2009&author=Slade%2CMJ&author=Payne%2CR&author=Riethdorf%2CS&author=Ward%2CB&author=Zaidi%2CSA&author=Stebbing%2CJ&author=Palmieri%2CC&author=Sinnett%2CHD&author=Kulinskaya%2CE&author=Pitfield%2CT&author=McCormack%2CRT&author=Pantel%2CK&author=Coombes%2CRC's total income per month
- Learn about the earnings of https://doi.org/10.1038%2Fnrclinonc.2009.44
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19399023
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Cancer%20micrometastases&journal=Nat%20Rev%20Clin%20Oncol&doi=10.1038%2Fnrclinonc.2009.44&volume=6&pages=339-351&publication_year=2009&author=Pantel%2CK&author=Alix-Panabieres%2CC&author=Riethdorf%2CS?
- Income figures for https://doi.org/10.1002%2Fcncr.25145
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20564098?
- Get to know http://scholar.google.com/scholar_lookup?&title=Detection%20of%20minimal%20residual%20disease%20in%20blood%20and%20bone%20marrow%20in%20early%20stage%20breast%20cancer&journal=Cancer&doi=10.1002%2Fcncr.25145&volume=116&pages=3330-3337&publication_year=2010&author=Krishnamurthy%2CS&author=Cristofanilli%2CM&author=Singh%2CB&author=Reuben%2CJ&author=Gao%2CH&author=Cohen%2CEN&author=Andreopoulou%2CE&author=Hall%2CCS&author=Lodhi%2CA&author=Jackson%2CS&author=Lucci%2CA's earnings
- Find out how much https://doi.org/10.1002%2Fijc.21576 earns monthly
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16287086?
- What's http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20the%20clinical%20significance%20of%20occult%20tumor%20cells%20in%20blood%20and%20bone%20marrow%20in%20breast%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.21576&volume=118&pages=2013-2019&publication_year=2006&author=Wiedswang%2CG&author=Borgen%2CE&author=Schirmer%2CC&author=Karesen%2CR&author=Kvalheim%2CG&author=Nesland%2CJM&author=Naume%2CB's gross income?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16495933
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361203's financial summary
- How much money does http://scholar.google.com/scholar_lookup?&title=Real-time%20RT-PCR%20detection%20of%20disseminated%20tumour%20cells%20in%20bone%20marrow%20has%20superior%20prognostic%20significance%20in%20comparison%20with%20circulating%20tumour%20cells%20in%20patients%20with%20breast%20cancer&journal=Br%20J%20Cancer&volume=94&pages=672-680&publication_year=2006&author=Benoy%2CIH&author=Elst%2CH&author=Philips%2CM&author=Wuyts%2CH&author=van%20Dam%2CP&author=Scharpe%2CS&author=van%20Marck%2CE&author=Vermeulen%2CPB&author=Dirix%2CLY generate?
- Financial intake of https://doi.org/10.1158%2F1078-0432.CCR-0102-03
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14977842?
- http://scholar.google.com/scholar_lookup?&title=Clinical%20significance%20of%20immunocytochemical%20detection%20of%20tumor%20cells%20using%20digital%20microscopy%20in%20peripheral%20blood%20and%20bone%20marrow%20of%20breast%20cancer%20patients&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-0102-03&volume=10&pages=1392-1400&publication_year=2004&author=Pierga%2CJY&author=Bonneton%2CC&author=Vincent-Salomon%2CA&author=de%20Cremoux%2CP&author=Nos%2CC&author=Blin%2CN&author=Pouillart%2CP&author=Thiery%2CJP&author=Magdelenat%2CH's financial summary
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19589136?
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750105 generate?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Stem%20cell%20and%20epithelial-mesenchymal%20transition%20markers%20are%20frequently%20overexpressed%20in%20circulating%20tumor%20cells%20of%20metastatic%20breast%20cancer%20patients&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr2333&volume=11&publication_year=2009&author=Aktas%2CB&author=Tewes%2CM&author=Fehm%2CT&author=Hauch%2CS&author=Kimmig%2CR&author=Kasimir-Bauer%2CS have monthly?
- How much revenue does https://doi.org/10.1073%2Fpnas.1331931100 generate?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12808139 makes per month
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC164657's total income per month
- How much money does http://scholar.google.com/scholar_lookup?&title=From%20latent%20disseminated%20cells%20to%20overt%20metastasis%3A%20genetic%20analysis%20of%20systemic%20breast%20cancer%20progression&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1331931100&volume=100&pages=7737-7742&publication_year=2003&author=Schmidt-Kittler%2CO&author=Ragg%2CT&author=Daskalakis%2CA&author=Granzow%2CM&author=Ahr%2CA&author=Blankenstein%2CTJ&author=Kaufmann%2CM&author=Diebold%2CJ&author=Arnholdt%2CH&author=Muller%2CP&author=Bischoff%2CJ&author=Harich%2CD&author=Schlimok%2CG&author=Riethmuller%2CG&author=Eils%2CR&author=Klein%2CCA make?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12114406
- How much profit does http://scholar.google.com/scholar_lookup?&title=Cytogenetic%20evidence%20that%20circulating%20epithelial%20cells%20in%20patients%20with%20carcinoma%20are%20malignant&journal=Clin%20Cancer%20Res&volume=8&pages=2073-2084&publication_year=2002&author=Fehm%2CT&author=Sagalowsky%2CA&author=Clifford%2CE&author=Beitsch%2CP&author=Saboorian%2CH&author=Euhus%2CD&author=Meng%2CS&author=Morrison%2CL&author=Tucker%2CT&author=Lane%2CN&author=Ghadimi%2CBM&author=Heselmeyer-Haddad%2CK&author=Ried%2CT&author=Rao%2CC&author=Uhr%2CJ make?
- http://scholar.google.com/scholar_lookup?&title=High-resolution%20analyses%20of%20copy%20number%20changes%20in%20disseminated%20tumor%20cells%20of%20patients%20with%20breast%20cancer&publication_year=2011&author=Mathiesen%2CRR&author=Fjelldal%2CR&author=Liestol%2CK&author=Due%2CEU&author=Geigl%2CJB&author=Riethdorf%2CS&author=Borgen%2CE&author=Rye%2CIH&author=Schneider%2CIJ&author=Obenauf%2CAC&author=Mauermann%2CO&author=Nilsen%2CG&author=Christian%20Lingjaerde%2CO&author=Borresen-Dale%2CAL&author=Pantel%2CK&author=Speicher%2CMR&author=Naume%2CB&author=Baumbusch%2CLO's total income per month
- How much revenue does https://doi.org/10.1038%2Fnature09807 produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21399628 generate monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504184?
- Profit of http://scholar.google.com/scholar_lookup?&title=Tumour%20evolution%20inferred%20by%20single-cell%20sequencing&journal=Nature&doi=10.1038%2Fnature09807&volume=472&pages=90-94&publication_year=2011&author=Navin%2CN&author=Kendall%2CJ&author=Troge%2CJ&author=Andrews%2CP&author=Rodgers%2CL&author=McIndoo%2CJ&author=Cook%2CK&author=Stepansky%2CA&author=Levy%2CD&author=Esposito%2CD&author=Muthuswamy%2CL&author=Krasnitz%2CA&author=McCombie%2CWR&author=Hicks%2CJ&author=Wigler%2CM
- https://doi.org/10.1073%2Fpnas.0402993101's financial summary
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15194824's earnings
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC438987 generate?
- How much money does http://scholar.google.com/scholar_lookup?&title=HER-2%20gene%20amplification%20can%20be%20acquired%20as%20breast%20cancer%20progresses&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0402993101&volume=101&pages=9393-9398&publication_year=2004&author=Meng%2CS&author=Tripathy%2CD&author=Shete%2CS&author=Ashfaq%2CR&author=Haley%2CB&author=Perkins%2CS&author=Beitsch%2CP&author=Khan%2CA&author=Euhus%2CD&author=Osborne%2CC&author=Frenkel%2CE&author=Hoover%2CS&author=Leitch%2CM&author=Clifford%2CE&author=Vitetta%2CE&author=Morrison%2CL&author=Herlyn%2CD&author=Terstappen%2CLW&author=Fleming%2CT&author=Fehm%2CT&author=Tucker%2CT&author=Lane%2CN&author=Wang%2CJ&author=Uhr%2CJ make?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1186/bcr3242?format=refman&flavour=references produce monthly?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Randi%20R%20Mathiesen?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Randi%20R%20Mathiesen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Elin%20Borgen income
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Elin%20Borgen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anne%20Renolen generate?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anne%20Renolen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Erik%20L%C3%B8kkevik?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Erik%20L%C3%B8kkevik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jahn%20M%20Nesland bring in each month?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jahn%20M%20Nesland%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gun%20Anker earns monthly
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gun%20Anker%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bj%C3%B8rn%20%C3%98stenstad
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bj%C3%B8rn%20%C3%98stenstad%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Steinar%20Lundgren make?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Steinar%20Lundgren%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Terje%20Risberg rake in every month?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Terje%20Risberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ingvil%20Mjaaland?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ingvil%20Mjaaland%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gunnar%20Kvalheim's earnings
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gunnar%20Kvalheim%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Per%20Eystein%20L%C3%B8nning generate?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Per%20Eystein%20L%C3%B8nning%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bj%C3%B8rn%20Naume each month?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bj%C3%B8rn%20Naume%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- How much revenue does https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_MOESM1_ESM.pdf produce monthly?
- How much does https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_MOESM2_ESM.pdf earn?
- What's the monthly income of https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_MOESM3_ESM.pdf?
- Monthly income for https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3242/MediaObjects/13058_2012_3049_MOESM4_ESM.pdf
- How profitable is http://creativecommons.org/licenses/by/2.0/?
- Explore the financials of https://s100.copyright.com/AppDispatchServlet?title=Persistence%20of%20disseminated%20tumor%20cells%20after%20neoadjuvant%20treatment%20for%20locally%20advanced%20breast%20cancer%20predicts%20poor%20survival&author=Randi%20R%20Mathiesen%20et%20al&contentID=10.1186%2Fbcr3242©right=Mathiesen%20et%20al.%3B%20licensee%20BioMed%20Central%20Ltd.&publication=1465-542X&publicationDate=2012-08-14&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
- Earnings of https://citation-needed.springer.com/v2/references/10.1186/bcr3242?format=refman&flavour=citation
- What are the total earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- How much does https://www.springernature.com/gp/products gross monthly?
- Earnings of https://www.springernature.com/gp/librarians
- https://www.springernature.com/gp/societies's total income per month
- Income figures for https://www.springernature.com/gp/partners
- What's the income generated by https://www.springer.com/ each month?
- How much does https://www.nature.com/ make?
- What's the total monthly financial gain of https://www.biomedcentral.com/?
- Explore the financials of https://www.palgrave.com/
- What's the financial outcome of https://www.apress.com/?
- What are the earnings of https://www.springernature.com/gp/legal/ccpa?
- What are the total earnings of https://www.springernature.com/gp/info/accessibility?
- How much revenue does https://support.springernature.com/en/support/home bring in?
- How much revenue does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations produce monthly?
- Earnings of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref